UnitedHealth Group (UNH) Rating Lowered to Hold at Zacks Investment Research
UnitedHealth Group (NYSE:UNH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday.
According to Zacks, “Shares of UnitedHealth Group have slightly underperformed the industry in a year’s time. The company’s robust Government business and continued strong growth at Optum are driving long-term growth. Its international business and strong capital position that allows for business investment are the other positives. It has been witnessing an increase in membership from past many years. The company raised its 2018 earnings guidance led by tax reform upside. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 15.4% upward over the last 90 days. Nevertheless, membership loss in its fee based commercial business and Brazilian business will pull down the overall membership growth.”
Several other analysts also recently issued reports on UNH. Cantor Fitzgerald restated a “buy” rating and issued a $225.00 price objective on shares of UnitedHealth Group in a research report on Monday, November 27th. Wells Fargo restated an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Oppenheimer upped their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the company an “outperform” rating in a research report on Wednesday, November 29th. Credit Suisse Group restated a “positive” rating and issued a $240.00 price objective (up from $233.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Finally, Royal Bank of Canada upped their price objective on UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $244.62.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the prior year, the business earned $2.11 earnings per share. The business’s revenue was up 9.5% on a year-over-year basis. sell-side analysts anticipate that UnitedHealth Group will post 12.51 EPS for the current fiscal year.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the sale, the director now directly owns 1,790,567 shares in the company, valued at $434,302,025.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $224.36, for a total value of $2,243,600.00. Following the sale, the director now owns 1,771,257 shares of the company’s stock, valued at $397,399,220.52. The disclosure for this sale can be found here. Insiders have sold 77,015 shares of company stock valued at $17,879,199 over the last 90 days. 0.89% of the stock is currently owned by insiders.
Large investors have recently made changes to their positions in the business. Beach Investment Management LLC. acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $556,000. Norinchukin Bank The grew its stake in shares of UnitedHealth Group by 24.5% in the second quarter. Norinchukin Bank The now owns 175,935 shares of the healthcare conglomerate’s stock valued at $32,622,000 after buying an additional 34,618 shares in the last quarter. Captrust Financial Advisors acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $2,556,000. Dorsey & Whitney Trust CO LLC grew its stake in shares of UnitedHealth Group by 25.0% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 16,798 shares of the healthcare conglomerate’s stock valued at $3,115,000 after buying an additional 3,357 shares in the last quarter. Finally, TCI Wealth Advisors Inc. grew its stake in shares of UnitedHealth Group by 1.5% in the second quarter. TCI Wealth Advisors Inc. now owns 1,609 shares of the healthcare conglomerate’s stock valued at $298,000 after buying an additional 23 shares in the last quarter. Institutional investors own 86.78% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was originally published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/unitedhealth-group-unh-rating-lowered-to-hold-at-zacks-investment-research/1955219.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.